GIPTIS
LIVE

Serial Number

79185059

Owner

PROTISVALOR MEDITERRANEE

Attorney

Patricia Smink Rogowski

Filing Date

Oct 16, 2015

Add to watchlist:

No watchlists yet
View on USPTO

GIPTIS Trademark

Serial Number: 79185059 • Registration: 5262909

GIPTIS is a trademark filed by PROTISVALOR MEDITERRANEE on October 16, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PROTISVALOR MEDITERRANEE

58 boulevard Charles Livon Jardin
Marseille F13007 , FR

Entity Type: 99

Trademark Details

Filing Date

October 16, 2015

Registration Date

August 15, 2017

Published for Opposition

May 30, 2017

Cancellation Date

October 16, 2025

Goods & Services

Medical services, in particular for the treatment of rare diseases; medical assistance, in particular for the treatment of rare diseases; rental of medical equipment, in particular for the treatment of rare diseases

Surgical apparatus and instruments; medical apparatus and instruments, namely, medical instruments for detecting the quality of collected specimens of human antibodies in plasma or dried blood, medical devices to facilitate the inhalation of pharmaceutical preparations; testing apparatus for medical use, namely, electro-cardiographs, instruments for measuring the pulse, electroencephalographs; blood testing apparatus; measuring devices for medical use, namely, devices for measuring the intracranial pressure; surgical prostheses, namely, bone prostheses, dental prostheses, and vascular prostheses; artificial limbs; body support medical devices, namely, supports for arms, legs, feet, neck, head and back for medical use; apparatus for measuring biological parameters of the human body and biological markers, in particular, biomarkers representative of rare diseases, namely, medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters; portable electronic devices for measuring biological parameters of the human body, namely, medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters

Food analysis apparatus, namely, diagnostic apparatus for testing food; gas analysis apparatus, namely, gas testing instruments

Business management and organization consultancy in the field of medicine; management of sales for technology and knowledge transfer operations; business administrative management of technology platforms for the research or processing of diseases, in particular in rare diseases

Training in the medical field, particularly in research or treatment of rare diseases; education in the medical field, particularly in research or treatment of rare diseases rendered through classes, seminars and workshops to train medical staff in particular for the treatment of rare diseases; publication of books, articles and journals conveying information in the medical field; arranging and conducting of colloquiums in the medical field; arranging and conducting of workshops in the medical field; publication of books in the field of medicine, particularly in research or treatment of rare diseases

Television broadcasting in the field of medicine, particularly in research or treatment of rare diseases; radio broadcasting in the field of medicine, particularly in research or treatment of rare diseases

Pharmaceutical products, in particular for the treatment of rare diseases in the nature of rare kidney diseases, rare cardiovascular diseases, rare hepato-gastro-enterological diseases, rare immunodeficiencies, developmental defects, neuromuscular diseases, rare neurological diseases, rare cardiovascular diseases, rare lung diseases, rare bone diseases, rare sensory disorders, rare skin diseases, rare diseases of connective tissue, rare endocrine diseases, rare hereditary metabolic diseases, rare nonmalignant hematologic disorders; preparations for medical use, in particular for the treatment of rare diseases in the nature of rare kidney diseases, rare cardiovascular diseases, rare hepato-gastro-enterological diseases, rare immunodeficiencies, developmental defects, neuromuscular diseases, rare neurological diseases, rare cardiovascular diseases, rare lung diseases, rare bone diseases, rare sensory disorders, rare skin diseases, rare diseases of connective tissue, rare endocrine diseases, rare hereditary metabolic diseases, rare nonmalignant hematologic disorders; biological tissue cultures for medical use; creams for medical use, in particular skin care creams and skin creams for the treatment of rare skin diseases

Scientific research services in the medical field; engineering services in the field of medicine; scientific studies, scientific research, scientific consultancy, scientific information, and scientific analysis relating to medicine, particularly in the field of research or treatment of rare diseases; research development, namely, scientific research services conducted in research collaboration; advisory services related to the operation of information technology, namely, consulting services in the use of computer hardware and software systems for others, relating to treatment of disease, in particular rare diseases; scientific and technological consultancy services in the medical field relating to methods and medical practices, in particular for the treatment of rare diseases; conducting medical clinical trials for others, particularly relating to the treatment of rare diseases; medical research in the field of human genetics; medical research relating to rare diseases

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 7, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
May 7, 2026 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Dec 14, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 22, 2024 INTS
INVALIDATION PROCESSED
Nov 21, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 2, 2024 INTR
CANCELLED SECTION 71
Mar 1, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 15, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 22, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 4, 2017 FICS
FINAL DISPOSITION PROCESSED
Dec 4, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 15, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 15, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 30, 2017 NPUB
PUBLISHED FOR OPPOSITION
May 30, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 10, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 24, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 21, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 21, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 21, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 21, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 21, 2017 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 25, 2016 GNRN
NON-FINAL ACTION E-MAILED
Oct 25, 2016 GNRT
NON-FINAL ACTION WRITTEN
Oct 25, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2016 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 30, 2016 CHAN
ASSIGNED TO LIE
Sep 30, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 14, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 14, 2016 REAP
REFUSAL PROCESSED BY IB
May 14, 2016 RFNT
APPLICATION FILING RECEIPT MAILED
Mar 29, 2016 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2016 RFCS
REFUSAL PROCESSED BY MPU
Mar 28, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 27, 2016 RFCR
NON-FINAL ACTION WRITTEN
Mar 26, 2016 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 25, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 24, 2016 REPR